Dr. Sarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
M893D, 513 Parnassus
University of California San Francisco
San Francisco, CA 94143Phone+1 415-502-7921
Summary
- Dr. Minnie Sarwal is an adult and pediatric medicine and surgery trained multi organ transplant physician in the Department of Surgery, Medicine and Pediatrics in the University of California in San Francisco, CA, where she codirects the Kidney- Pancreas Transplant Program, the T32 Surgery Training program and the NIH funded Sarwal Lab in Precision Transplant Medicine. She headed the Pediatric Kidney Transplant Program at Stanford with joint appointments in Pediatrics, Surgery and Immunology. She is a key opinion leader for the Transplantation Society and has held multiple leadership positions at the FDA, NIH, Dept of Defense, and Faculty Senates and Stanford and UCSF. She holds her medical degrees from Calcutta Medical College (India), and Guys Hospital, London (UK). She gained her PhD in Molecular Genetics from Cambridge University (UK) and holds a Diploma in Child Health (DCH), MRCP and FRCP degrees from London (UK). She has been in practice 30 years. She specializes in pre and post transplant care, transplant immunology, bioinformatics and AI applications in transplant and renal disease, renal failure and molecular and cellular research in transplant and renal injury. She teaches as a Capstone mentor for the Masters in Translational Medicine Program at UCSF and UC Berkeley.
Education & Training
- Cambridge University, Christs College, UKPhD, Molecular Genetics, 1992 - 1995
- Guys Hospital, London UKMRCP, DCH, 1990 - 1993
- Calcutta medical college indiaClass of 1987
Certifications & Licensure
- CA State Medical License 1999 - 2025
Awards, Honors, & Recognition
- Cuneo RichardSon Award for Excellence in Nephrology Research National Kidney Foundation, 2012
- TTS Translational Science Outstanding Faculty TTS, 2012
Clinical Trials
- Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation Start of enrollment: 2004 Mar 01
- Rituximab for Pediatric Renal Transplant Rejection Start of enrollment: 2005 Jun 01
- KIDney Injury in Times of COVID-19 (KIDCOV) Start of enrollment: 2021 Mar 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.Audrey E Brown, Yvonne M Kelly, Arya Zarinsefat, Raphael P H Meier, Giulia Worner
American Journal of Transplantation. 2025-02-01 - Natural Killer Cell Phenotypes and Clinical Outcomes in Pediatric Kidney Transplantation.Riley H Kahan, Nader Abraham, Hui-Jie Lee, Robert B Ettenger, Paul C Grimm
Pediatric Transplantation. 2024-12-01 - 3 citationsOrgan Donation and Transplantation Registries Across the Globe: A Review of the Current State.Christie Rampersad, Curie Ahn, Chris Callaghan, Beatriz Dominguez-Gil, Gustavo F Ferreira
Transplantation. 2024-10-01
Press Mentions
- NephroSant Publishes Real-World Evidence Showing Potential to Improve the Detection of Early Rejection Events with QSantMarch 3rd, 2022
- NephroSant Executives Recognized for Contributions to Transplant Care and Advocacy by Prestigious Industry GroupsAugust 16th, 2021
- NephroSant Hires Gina Ford as CCO to Lead Global Commercialization StrategyAugust 6th, 2021
- Join now to see all
Grant Support
- Mechanisms of rFSGSNIH2017–2022
Professional Memberships
- Member
External Links
- LinkedInhttp://linkedin.com/in/minnie-sarwal-mdphd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: